Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

241

Eventide Asset ManagementLatest Jul 15

AdvanCell · $315M Series D Leo Cancer Care · $65M Series D

2rounds

—led

Biotech 1Healthtech 1

Series C+ 2

Jul 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

AdvanCell $315M Series D Leo Cancer Care $65M Series D

242

SymBiosisLatest Jul 15

AdvanCell · $315M Series D SonoThera · $125M Series B

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jul 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

AdvanCell $315M Series D SonoThera $125M Series B

243

Time BioVenturesLatest Jul 15

AdvanCell · $315M Series D Waypoint Bio · $20M Series A

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Jul 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

AdvanCell $315M Series D Waypoint Bio $20M Series A

244

ICGLatest Jul 14

Draig Therapeutics · $65M Series B Mediar Therapeutics · $76M Series B

2rounds

—led

Biotech 2

Series B 2

Jul 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Draig Therapeutics $65M Series B Mediar Therapeutics $76M Series B

245

Schroders CapitalLatest Jul 14

Draig Therapeutics · $65M Series B Kinaset Therapeutics · $103M Series B

2rounds

—led

Biotech 2

Series B 2

Jul 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Draig Therapeutics $65M Series B Kinaset Therapeutics $103M Series B

246

Bain Capital VenturesLatest Jul 13

Chai Discovery · $400M Series C Loyal · $100M Series C

2rounds

—led

Biotech 2

Series C+ 2

Jul 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Chai Discovery $400M Series C Loyal $100M Series C

247

Battery VenturesLatest Jul 13

Chai Discovery · $400M Series C Triomics · $22M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 1, Series C+ 1

Jul 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Chai Discovery $400M Series C Triomics $22M Series B

248

Index VenturesLatest Jul 13

Chai Discovery · $400M Series C Sequential · $3.5M Seed

2rounds

—led

Biotech 1Healthtech 1

Seed 1, Series C+ 1

Jul 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Chai Discovery $400M Series C Sequential $3.5M Seed

249

Kleiner PerkinsLatest Jul 13

Chai Discovery · $400M Series C Health Universe · $6M Seed

2rounds

—led

Biotech 1Healthtech 1

Seed 1, Series C+ 1

Jul 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Chai Discovery $400M Series C Health Universe $6M Seed

250

Thrive CapitalLatest Jul 13

Chai Discovery · $400M Series C Isomorphic Labs · $2.1B Series B

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jul 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Chai Discovery $400M Series C Isomorphic Labs $2.1B Series B

251

Blood Cancer United's Therapy Acceleration ProgramLatest Jul 8

Allotera Therapeutics · $35M Series C extension and venture debt Crossbow Therapeutics · $77M Series B

2rounds

0led

Biotech 2

Series B 1, Series C+ 1

Jul 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Allotera Therapeutics $35M Series C extension and venture debt Crossbow Therapeutics $77M Series B

252

Conception X Angel SyndicateLatest Jul 8

Respiro Diagnostics · £1M Pre-Seed QMatter · $1.2M Pre-Seed

2rounds

—led

Hardware 1Healthtech 1

Pre-seed 2

Jul 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 2

Respiro Diagnostics £1M Pre-Seed QMatter $1.2M Pre-Seed

253

FoodLabsLatest Jul 8

Aardaia · €5M Seed Pacifico Biolabs · €7M Series A

2rounds

—led

Agritech 1Foodtech 1

Seed 1, Series A 1

Jul 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Aardaia €5M Seed Pacifico Biolabs €7M Series A

254

SFC CapitalLatest Jul 8

Respiro Diagnostics · £1M Pre-Seed Healome Therapeutics · £2M Seed

2rounds

—led

Biotech 1Healthtech 1

Pre-seed 1, Seed 1

Jul 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

Respiro Diagnostics £1M Pre-Seed Healome Therapeutics £2M Seed

255

Empirical VenturesLatest Jul 7

Healome Therapeutics · £2M Seed OutSee · £2.5M Seed

2rounds

—led

Biotech 2

Seed 2

Jul 7, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

Healome Therapeutics £2M Seed OutSee £2.5M Seed

256

GordonMD Global InvestmentsLatest Jul 7

Cyllene Therapeutics · €33M Series C Rapalogix Health · $20M Series A

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Jul 7, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Cyllene Therapeutics €33M Series C Rapalogix Health $20M Series A

257

HealthCapLatest Jul 6

CurifyLabs · $14M Series A Adcendo · $75M Series C

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Series C+ 1

Jul 6, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

CurifyLabs $14M Series A Adcendo $75M Series C

258

Lifeline VenturesLatest Jul 6

CurifyLabs · $14M Series A Elea & Lili · €2.5M Seed

2rounds

—led

Climate tech 1Healthtech 1

Seed 1, Series A 1

Jul 6, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

CurifyLabs $14M Series A Elea & Lili €2.5M Seed

259

LifeArcLatest Jun 24

RQ Bio · $115M Series A Exciva · €51M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Jun 24, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

RQ Bio $115M Series A Exciva €51M Series B

260

Inc.Latest Jun 23

TRIMTECH Therapeutics · $47M Seed+Mirador Therapeutics · $250M Series B

2rounds

—led

Biotech 2

Seed 1, Series B 1

Jun 23, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

TRIMTECH Therapeutics $47M Seed+Mirador Therapeutics $250M Series B

261

Start CodonLatest Jun 23

TRIMTECH Therapeutics · $47M Seed+Semarion · $3.8M Undisclosed

2rounds

—led

Biotech 2

Seed 1, Undisclosed 1

Jun 23, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

TRIMTECH Therapeutics $47M Seed+Semarion $3.8M Undisclosed

262

Arkin Bio CapitalLatest Jun 22

Bionyra Pharma · $165M Series A Crossbow Therapeutics · $77M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Bionyra Pharma $165M Series A Crossbow Therapeutics $77M Series B

263

Jeito CapitalLatest Jun 22

Bionyra Pharma · $165M Series A Adcendo · $75M Series C

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Bionyra Pharma $165M Series A Adcendo $75M Series C

264

Merantix CapitalLatest Jun 22

Graph Therapeutics · $5M Series A Outpost Bio · $3.5M Pre-Seed

2rounds

—led

Biotech 2

Pre-seed 1, Series A 1

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Series A 1

Graph Therapeutics $5M Series A Outpost Bio $3.5M Pre-Seed

265

SEEDSLatest Jun 22

ChemT Biotechnology · $4M Seed Protuoso Biosciences · $9.5M Seed

2rounds

—led

Biotech 2

Seed 2

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

ChemT Biotechnology $4M Seed Protuoso Biosciences $9.5M Seed

266

SquareOneLatest Jun 22

Graph Therapeutics · $5M Series A Flinn · $20M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 2

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Graph Therapeutics $5M Series A Flinn $20M Series A

267

Vives PartnersLatest Jun 22

Bionyra Pharma · $165M Series A Generare · €20M Series A

2rounds

—led

Biotech 2

Series A 2

Jun 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Bionyra Pharma $165M Series A Generare €20M Series A

268

Astellas Venture ManagementLatest Jun 21

Syntax Bio · $14.4M Series A+Sidewinder Therapeutics · $137M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Jun 21, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Syntax Bio $14.4M Series A+Sidewinder Therapeutics $137M Series B

269

AccelLatest Jun 17

Pramaana Labs · $27M Seed Turbine · $25M Series B

2rounds

—led

Biotech 1Enterprise software 1

Seed 1, Series B 1

Jun 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

Pramaana Labs $27M Seed Turbine $25M Series B

270

Atlas VentureLatest Jun 17

Triveni Bio · $65M Series C Kinaset Therapeutics · $103M Series B

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jun 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Triveni Bio $65M Series C Kinaset Therapeutics $103M Series B

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.